Alexion Pharmaceuticals
Alexion Pharmaceuticals is best known for developing drugs used to treat rare disorders. The company is the original developer of Soliris, a unique medication used to treat hemolytic-uremic syndrome and paroxysmal nocturnal hemoglobinuria – potentially fatal blood conditions. In 2010, Alexion was applauded for donating Soliris to people in Germany who had fallen victims to […]
Alexion Pharmaceuticals is best known for developing drugs used to treat rare disorders. The company is the original developer of Soliris, a unique medication used to treat hemolytic-uremic syndrome and paroxysmal nocturnal hemoglobinuria – potentially fatal blood conditions. In 2010, Alexion was applauded for donating Soliris to people in Germany who had fallen victims to an E. coli outbreak. The company is currently researching eculizumab, a treatment for neurological disorders and conditions linked to transplants.